TB Alternative Assets Ltd. cut its stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 45.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 41,639 shares of the company’s stock after selling 35,061 shares during the quarter. Direxion Daily S&P Biotech Bull 3x Shares comprises approximately 1.3% of TB Alternative Assets Ltd.’s portfolio, making the stock its 20th biggest holding. TB Alternative Assets Ltd.’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $5,361,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at about $43,000. McGuire Investment Group LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 3.9% in the 3rd quarter. McGuire Investment Group LLC now owns 4,633 shares of the company’s stock valued at $596,000 after acquiring an additional 175 shares during the last quarter. SG Americas Securities LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 49.3% in the 3rd quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock valued at $412,000 after acquiring an additional 1,057 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 2nd quarter valued at about $68,000. Finally, Foundations Investment Advisors LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 25.3% in the 2nd quarter. Foundations Investment Advisors LLC now owns 4,087 shares of the company’s stock valued at $464,000 after acquiring an additional 825 shares during the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Trading Up 1.4 %
LABU stock opened at $131.10 on Monday. Direxion Daily S&P Biotech Bull 3x Shares has a 12 month low of $48.40 and a 12 month high of $176.99. The firm has a 50-day moving average of $130.85 and a two-hundred day moving average of $119.27.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Here’s Why AMD Can’t Catch Up Soon to NVIDIA’s AI
- Do ETFs Pay Dividends? What You Need to Know
- Don’t Miss These 3 Japanese Stocks as Interest Rates Climb
- Stock Splits, Do They Really Impact Investors?
- Oversold But Ready to Rally: 5 Stocks to Watch Now
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.